Stereotaxis, Inc.
Maple Grove, MN 55369
Share:
Software offers interventional lab integration.
Odyssey(TM) consolidates multiple diagnostic information sources in interventional electrophysiology lab including x-ray fluoroscopy, mapping systems, and heart-rate monitoring systems into single display and networked user interface. It can be connected through IP Virtual Private Network (VPN) Service to remote Clinical Services Center, providing users with remote on demand technical support and...
Read More »Stereotaxis Announces Initial U.S. Clinical Usage of Partnered 3-D Localized Ablation Catheter with Company's Niobe-® System
ST. LOUIS, Feb. 23 - Stereotaxis, Inc. (NASDAQ:STXS) today announced that Central Baptist Hospital-Lexington, KY became the first U.S. center to successfully treat a patient's cardiac arrhythmia using our partnered 3-D Localized Ablation Catheter. This diagnostic and ablation catheter recently received FDA approval for use with the Stereotaxis NiobeÃ-® Magnetic Navigation System. This...
Read More »Stereotaxis to Present at the Bear Stearns 20th Annual Healthcare Conference
ST. LOUIS, Sept. 5 /-- Stereotaxis, Inc. (NASDAQ:STXS), announced today that Bevil J. Hogg, Chief Executive Officer, and James M. Stolze, Chief Financial Officer, will present at the Bear Stearns 20th Annual Healthcare Conference at the Grand Hyatt New York, on Tuesday, September 11, 2007 at 2:30 p.m. Eastern Time. Attendance at the conference is by invitation only. The audio presentation will be...
Read More »Software offers interventional lab integration.
Odyssey(TM) consolidates multiple diagnostic information sources in interventional electrophysiology lab including x-ray fluoroscopy, mapping systems, and heart-rate monitoring systems into single display and networked user interface. It can be connected through IP Virtual Private Network (VPN) Service to remote Clinical Services Center, providing users with remote on demand technical support and...
Read More »Biosense Webster and Stereotaxis Expand Strategic Alliance and Extend Current Agreement
DIAMOND BAR, Calif. and ST. LOUIS, May 9 : Biosense Webster, Inc., and Stereotaxis, Inc. (NASDAQ:STXS) today announced an expanded strategic alliance to integrate technology platforms, specifically the Stereotaxis Niobe System and the Biosense Webster CartoÃ-® EP Navigation System. The two companies also extended by two years the current worldwide agreement for the development and...
Read More »Stereotaxis Announces Initial U.S. Clinical Usage of Partnered 3-D Localized Ablation Catheter with Company's Niobe-® System
ST. LOUIS, Feb. 23 - Stereotaxis, Inc. (NASDAQ:STXS) today announced that Central Baptist Hospital-Lexington, KY became the first U.S. center to successfully treat a patient's cardiac arrhythmia using our partnered 3-D Localized Ablation Catheter. This diagnostic and ablation catheter recently received FDA approval for use with the Stereotaxis NiobeÃ-® Magnetic Navigation System. This...
Read More »